Related Experiment Video
Updated: Aug 6, 2026

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
Published on: September 1, 2023
Self-amplifying mRNA vaccine cocktail against Staphylococcus aureus: A multi-epitope immunoinformatics and structural
Aysan Salemi1, Mohammad M Pourseif2,3,4, Behzad Jafari5
1Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
This study designed a bivalent self-amplifying mRNA (saRNA) vaccine cocktail against Staphylococcus aureus. Computational analysis shows the candidate vaccines are safe, stable, and potentially immunogenic, supporting further research.
Area of Science:
- Vaccinology
- Computational Biology
- Infectious Disease
Background:
- Staphylococcus aureus (S. aureus) is a major global health concern with no existing human vaccine.
- Urgent need for non-antibiotic prophylactic strategies against invasive S. aureus infections.
Purpose of the Study:
- To design and computationally evaluate a bivalent self-amplifying mRNA (saRNA) vaccine cocktail targeting key S. aureus virulence factors.
- To assess the safety, stability, and immunogenic potential of novel saRNA vaccine candidates.
Main Methods:
- Utilized immunoinformatics, structural bioinformatics, and molecular simulations to identify immunodominant epitopes.
- Designed two saRNA candidates (SaBVax807, SaTVax876) and validated binding interactions using molecular docking and dynamics.
- Performed codon optimization and comprehensive in silico safety and immunogenicity assessments.
Main Results:
- Developed two saRNA vaccine candidates, SaBVax807 and SaTVax876, targeting S. aureus ClfA, Hly, and SraP antigens.
- Computational analyses indicated favorable safety, structural stability, and predicted immunogenicity for the saRNA cocktail.
- Population coverage analysis suggested global applicability for SaTVax876.
Conclusions:
- The designed saRNA vaccine cocktail demonstrates promising safety and immunogenic profiles against S. aureus.
- This study provides a strong computational foundation for advancing these candidate vaccines towards preclinical and clinical development.
- Further investigation is warranted to validate the efficacy of these novel S. aureus vaccines.
More Related Videos
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
10:58Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019